JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB120183

Angiotensin II (human), Vasoconstrictor peptide

4

(1 Review)

|

(27 Publications)

Angiotensin II (Angiotensin II) (ab120183) is a vasoconstrictor and a bioactive peptide of the renin/angiotensin system. MW 1046.2.

- Available in different sizes to fit your experimental needs
- Cited in over 20 publications
1 Images
Chemical Structure - Angiotensin II (human), Vasoconstrictor peptide (AB120183)
  • Chemical Structure

Lab

Chemical Structure - Angiotensin II (human), Vasoconstrictor peptide (AB120183)

2D chemical structure image of ab120183, Angiotensin II (human), Vasoconstrictor peptide

Key facts

CAS number

4474-91-3

Purity

>95%

Form

Solid

form

Molecular weight

1046.2 Da

Molecular formula

C<sub>5</sub><sub>0</sub>H<sub>7</sub><sub>1</sub>N<sub>1</sub><sub>3</sub>O<sub>1</sub><sub>2</sub>

PubChem

172198

Nature

Synthetic

Solubility

Soluble in water to 1mg/ml

Biochemical name

Angiotensin II

Canonical smiles

CCC(C)C(C(=O)NC(CC1=CN=CN1)C(=O)N2CCCC2C(=O)NC(CC3=CC=CC=C3)C(=O)O)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(C(C)C)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC(=O)O)N

Isomeric smiles

CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)O)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)O)N

InChi

InChI=1S/C50H71N13O12/c1-5-28(4)41(47(72)59-36(23-31-25-54-26-56-31)48(73)63-20-10-14-38(63)45(70)60-37(49(74)75)22-29-11-7-6-8-12-29)62-44(69)35(21-30-15-17-32(64)18-16-30)58-46(71)40(27(2)3)61-43(68)34(13-9-19-55-50(52)53)57-42(67)33(51)24-39(65)66/h6-8,11-12,15-18,25-28,33-38,40-41,64H,5,9-10,13-14,19-24,51H2,1-4H3,(H,54,56)(H,57,67)(H,58,71)(H,59,72)(H,60,70)(H,61,68)(H,62,69)(H,65,66)(H,74,75)(H4,52,53,55)/t28-,33-,34-,35-,36-,37-,38-,40-,41-/m0/s1

InChiKey

CZGUSIXMZVURDU-JZXHSEFVSA-N

IUPAC Name

(3S)-3-amino-4-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[(2S)-2-[[(1S)-1-carboxy-2-phenylethyl]carbamoyl]pyrrolidin-1-yl]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-oxobutanoic acid

Product details

Check out our range of Vasoconstrictor peptide biochemicals here

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

AGTR1 and AGTR2 have implications in hypertension and heart failure. Overactivation of AGTR1 is often linked with hypertension due to its vasoconstrictive action and fluid retention. Angiotensin receptor blockers (ARBs) target AGTR1 to treat hypertension by inhibiting angiotensin II binding. AGTR2 by mediating vasodilation plays a protective role in cardiovascular diseases but can also get involved in pathological conditions like fibrosis when dysregulated. Both receptors but predominantly AGTR1 associate with conditions like diabetic nephropathy because they affect renal function. The angiotensin-converting enzyme (ACE) remains a critical upstream regulator in these disease contexts as it modulates the production of angiotensin II.
Pathways

AGTR1 and AGTR2 interact mainly with the renin-angiotensin-aldosterone system (RAAS) and counter-regulatory pathways like nitric oxide production. AGTR1 activation by angiotensin II influences the RAAS by triggering G-protein signaling cascades leading to the activation of phospholipase C and subsequent inositol triphosphate production. This pathway results in calcium release promoting muscle contraction. AGTR2 can modulate nitric oxide and bradykinin pathways providing vasodilation and antiproliferative effects. Proteins like angiotensin-converting enzyme (ACE) and renin help regulate these pathways through their role in converting angiotensinogen to angiotensin I then to angiotensin II.

Biological function summary

These receptors function distinctly despite both interacting with the angiotensin II peptide. AGTR1 is the major mediator of the angiotensin II-induced vasoconstriction and aldosterone secretion facilitating sodium retention and influencing cardiovascular function. AGTR2 although it binds the same peptide is involved in cellular growth and differentiation displaying roles in neuroprotection and promoting vasodilation. These receptors do not form complexes like ion channels but function independently to fine-tune physiological responses.

Angiotensin II Type 1 Receptor (AGTR1) and Angiotensin II Type 2 Receptor (AGTR2) play key roles in the renin-angiotensin system which regulates blood pressure and fluid balance. AGTR1 also called AT1 receptor typically binds angiotensin II a vasoconstrictor peptide leading to vasoconstriction and an increase in blood pressure. AGTR1 has a molecular mass of approximately 41 kDa and primarily expresses in vascular smooth muscle cells the heart liver kidney and adrenal gland. AGTR2 often called AT2 receptor shares similar angiotensin II binding but can mediate effects counter to AGTR1 such as vasodilation.

Product protocols

Publications (27)

Recent publications for all applications. Explore the full list and refine your search

Clinical and translational medicine 15:e70361 PubMed40468620

2025

DDR2-mediated autophagy inhibition contributes to angiotensin II-induced adventitial remodeling.

Applications

Unspecified application

Species

Unspecified reactive species

Gaojian Huang,Zhilei Cong,Yuhao Zhao,Tong Zhu,Ruosen Yuan,Zhen Li,Xuelian Wang,Jia Qi

Frontiers in cell and developmental biology 13:1476329 PubMed40109358

2025

New evidence for T-cadherin in COVID-19 pathogenesis, endothelial dysfunction, and lung fibrosis.

Applications

Unspecified application

Species

Unspecified reactive species

Ekaterina Semina,Vladimir Popov,Nikita Khabibullin,Polina Klimovich,Veronika Sysoeva,Ella Kurilina,Zoya Tsokolaeva,Vsevolod Tkachuk,Kseniya Rubina

Pharmaceuticals (Basel, Switzerland) 17: PubMed39338362

2024

Gastrodin Alleviates Angiotensin II-Induced Hypertension and Myocardial Apoptosis via Inhibition of the PRDX2/p53 Pathway In Vivo and In Vitro.

Applications

Unspecified application

Species

Unspecified reactive species

Nanhui Xu,Qiurong Xie,Youqin Chen,Jiapeng Li,Xiuli Zhang,Huifang Zheng,Ying Cheng,Meizhu Wu,Aling Shen,Lihui Wei,Mengying Yao,Yanyan Yang,Thomas J Sferra,Anjum Jafri,Yi Fang,Jun Peng

Cellular and molecular life sciences : CMLS 81:264 PubMed38878214

2024

Prostaglandin I signaling prevents angiotensin II-induced atrial remodeling and vulnerability to atrial fibrillation in mice.

Applications

Unspecified application

Species

Unspecified reactive species

Yue Zhang,Meng Yuan,Wenbin Cai,Weiyan Sun,Xuelian Shi,Daiqi Liu,Wenhua Song,Yingqun Yan,Tienan Chen,Qiankun Bao,Bangying Zhang,Tong Liu,Yi Zhu,Xu Zhang,Guangping Li

EMBO reports 25:1987-2014 PubMed38454158

2024

α-Melanocyte-stimulating hormone alleviates pathological cardiac remodeling via melanocortin 5 receptor.

Applications

Unspecified application

Species

Unspecified reactive species

Anni Suominen,Guillem Saldo Rubio,Saku Ruohonen,Zoltán Szabó,Lotta Pohjolainen,Bishwa Ghimire,Suvi T Ruohonen,Karla Saukkonen,Jani Ijas,Sini Skarp,Leena Kaikkonen,Minying Cai,Sharon L Wardlaw,Heikki Ruskoaho,Virpi Talman,Eriika Savontaus,Risto Kerkelä,Petteri Rinne

International journal of molecular sciences 25: PubMed38397098

2024

Novel Immortalized Human Multipotent Mesenchymal Stromal Cell Line for Studying Hormonal Signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Alexandra Primak,Natalia Kalinina,Mariya Skryabina,Vladimir Usachev,Vadim Chechekhin,Maksim Vigovskiy,Elizaveta Chechekhina,Nikita Voloshin,Konstantin Kulebyakin,Maria Kulebyakina,Olga Grigorieva,Pyotr Tyurin-Kuzmin,Nataliya Basalova,Anastasia Efimenko,Stalik Dzhauari,Yulia Antropova,Ivan Plyushchii,Zhanna Akopyan,Veronika Sysoeva,Vsevolod Tkachuk,Maxim Karagyaur

Cell death and differentiation 31:239-253 PubMed38182899

2024

TREM2 macrophage promotes cardiac repair in myocardial infarction by reprogramming metabolism via SLC25A53.

Applications

Unspecified application

Species

Unspecified reactive species

Shiyu Gong,Ming Zhai,Jiayun Shi,Guanye Yu,Zhijun Lei,Yefei Shi,Yanxi Zeng,Peinan Ju,Na Yang,Zhuo Zhang,Donghui Zhang,Jianhui Zhuang,Qing Yu,Xumin Zhang,Weixia Jian,Wei Wang,Wenhui Peng

Journal of the American Society of Nephrology : JASN 34:1647-1671 PubMed37725437

2023

Erythrocyte ENT1-AMPD3 Axis is an Essential Purinergic Hypoxia Sensor and Energy Regulator Combating CKD in a Mouse Model.

Applications

Unspecified application

Species

Unspecified reactive species

Changhan Chen,TingTing Xie,Yujin Zhang,Yiyan Wang,Fang Yu,Lizhen Lin,Weiru Zhang,Benjamin C Brown,Xin Zhang,Rodney E Kellems,Angelo D'Alessandro,Yang Xia

Frontiers in cardiovascular medicine 10:1110707 PubMed37593150

2023

Cfa-circ002203 was upregulated in rapidly paced atria of dogs and involved in the mechanisms of atrial fibrosis.

Applications

Unspecified application

Species

Unspecified reactive species

Wenfeng Shangguan,Tianshu Gu,Rukun Cheng,Xing Liu,Yu Liu,Shuai Miao,Weiding Wang,Fang Song,Hualing Wang,Tong Liu,Xue Liang

Scientific reports 13:12140 PubMed37495624

2023

Based on network pharmacology, gastrodin attenuates hypertension-induced vascular smooth muscle cell proliferation and PI3K/AKT pathway activation.

Applications

Unspecified application

Species

Unspecified reactive species

Aling Shen,Meizhu Wu,Farman Ali,Zhi Guo,Yi Fang,Yuting Zhou,Siyu Zhang,Wenqiang Zhang,Ying Wen,Min Yu,Jun Peng,Keji Chen
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com